These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3261834)

  • 1. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
    Hoekzema R; Martens M; Brouwer MC; Hack CE
    Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments.
    Kilchherr E; Schumaker VN; Bianchino AC; Curtiss LK
    J Immunol; 1987 Feb; 138(3):849-55. PubMed ID: 3492535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of C1 by monoclonal antibodies directed against C1q.
    Kilchherr E; Schumaker VN; Curtiss LK
    Biochem Biophys Res Commun; 1985 Jan; 126(2):785-91. PubMed ID: 3872122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
    Boackle RJ; Connor MH; Vesely J
    Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
    Bindon CI; Hale G; Brüggemann M; Waldmann H
    J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
    Heinz HP; Dlugonska H; Rüde E; Loos M
    J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies.
    Hughes-Jones NC; Gorick BD; Howard JC
    Eur J Immunol; 1983 Aug; 13(8):635-41. PubMed ID: 6603980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways.
    Bindon CI; Hale G; Hughes-Jones N; Gorick B; Waldmann H
    Mol Immunol; 1987 Jun; 24(6):587-94. PubMed ID: 2958690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding site for C1q on IgG.
    Duncan AR; Winter G
    Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E; Fuchs H; Tschopp J; Engel J
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first component of human complement (C1): activation and control.
    Ziccardi RJ
    Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.